The Burden of the Serious and Difficult-to-Treat Infections and a New Antibiotic Available: Cefiderocol

Overview of attention for article published in Frontiers in Pharmacology, January 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 32 Dimensions

Readers on

mendeley: 58 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 32 publications that cite this research output.

32

The most recent citing publications are shown below. View all 32 publications that cite this research output on Dimensions.

Emergence of aztreonam/avibactam and tigecycline-resistant Pseudomonas putida group Co-producing bla IMP-1, bla AFM-4 and bla OXA-1041 with a novel sequence type ST268 in Southwestern China

Article in Microbial Pathogenesis (April 2024)

The prevalence of gram-negative bacteria with difficult-to-treat resistance and utilization of novel β-lactam antibiotics in the southeastern United States

Article in Antimicrobial Stewardship & Healthcare Epidemiology (March 2024)

Evaluation of antibiofilm activity of cefiderocol alone and in combination with imipenem against Pseudomonas aeruginosa

Article in Journal of Global Antimicrobial Resistance (February 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.